Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | AR | P10275 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 3/20 | 0.45 |
| ▸ | KIT | P10721 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | SGK1 | O00141 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9297729 | 0.95 | THRA (0.52) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL11822352 | 0.93 | THRA (0.51) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL8091305 | 0.93 | THRA (0.51) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL8982739 | 0.93 | THRA (0.51) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL2537144 | 0.91 | PGR (0.48) | HPGDLMNAARKDM4ETHRA | |
| SCHEMBL486249 | 0.84 | HPGD (0.59) | HPGDLMNAARMAPTAURKA | |
| SCHEMBL4650966 | 0.83 | AR (0.66) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL9850091 | 0.82 | AR (0.47) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL4136916 | 0.81 | AR (0.39) | HPGDLMNAARKDM4EALDH1A1 | |
| SCHEMBL9156206 | 0.81 | HPGD (0.60) | HPGDLMNAARKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592426-B1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | NOVARTIS AG (CH) | 2007-12-19 | — | — | EP | claimed |
| US-20060247251-A1 | 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof | NOVARTIS AG (CH) | 2006-11-02 | — | — | US | claimed |
| EP-1592426-A1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | Novartis AG (CH) | 2005-11-09 | — | — | EP | claimed |
| WO-2004069256-A1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | NOVARTIS AG (CH) | 2004-08-19 | — | — | WO | claimed |
| EP-4209482-A1 | DYE COMPOSITION, INKJET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND DYE COMPOUND | FUJIFILM Corporation (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-20230183489-A1 | COLORING COMPOSITION, INK JET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND COLORING AGENT COMPOUND | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| CN-115989214-A | Pigment composition, inkjet recording method, image recorded matter, and pigment compound | 富士胶片株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-113631392-B | Inkjet ink, infrared absorption image forming method, and image forming method | 富士胶片株式会社 | 2023-02-14 | — | — | CN | disclosed |
| CN-114729218-A | Ink composition for inkjet recording and image recording method | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| CN-113631392-A | Inkjet ink for infrared-absorbing image formation, infrared-absorbing image formation method, and image formation method | 富士胶片株式会社 | 2021-11-09 | — | — | CN | disclosed |
| WO-2021095372-A1 | INK COMPOSITION FOR INK-JET RECORDING AND METHOD FOR RECORDING IMAGE | 富士フイルム株式会社 | 2021-05-20 | — | — | WO | disclosed |
| WO-2020202773-A1 | INKJET INK FOR FORMING INFRARED ABSORBING IMAGE, METHOD FOR FORMING INFRARED ABSORBING IMAGE, AND METHOD FOR FORMING IMAGE | 富士フイルム株式会社 | 2020-10-08 | — | — | WO | disclosed |
| US-4820816-A | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0299728-A2 | Carbonylation process for beta-lactam antibiotics | ELI LILLY AND COMPANY (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4791106-A | 1-Carbacephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1988-12-13 | — | — | US | disclosed |
| US-4778884-A | REACTING TRIFLUOROMETHYLSULFONYLOXY COMPOUND WITH LITHIUM HALIDE IN APROTIC POLAR SOLVENT | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 1988-10-18 | — | — | US | disclosed |
| US-4769325-A | 2-(Allenyl)penicillins | BALDWIN JACK E (GB) | 1988-09-06 | — | — | US | disclosed |
| EP-0232623-A1 | 1-Carbacephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1987-08-19 | — | — | EP | disclosed |
| US-4673737-A | ANTIBIOTICS/ | HARVARD UNIVERSITY (US) | 1987-06-16 | — | — | US | disclosed |
| EP-0218323-A1 | 2-Propadienyl penicillin derivatives and intermediates | Baldwin, Jack Edward (GB) | 1987-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247251-A1 | 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof | DPYD, P2RY1, P2RY2 | HPGD 340/4885LMNA 4551/4885AR 4689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.